Latest & greatest articles for Risk Management

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Risk Management or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Risk Management and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Risk Management

1. Management of patients with increased risk for familial pancreatic cancer

Management of patients with increased risk for familial pancreatic cancer 1 Goggins M, et al. Gut 2019;0:1–11. doi:10.1136/gutjnl-2019-319352 Guidelines Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium Michael Goggins , 1 Kasper Alexander Overbeek , 2 Randall Brand, 3 Sapna Syngal, 4 Marco Del Chiaro, 5 Detlef K Bartsch, 6 Claudio Bassi, 7 Alfredo Carrato, 8 James Farrell (...) and permissions. Published by BMJ. AbsTrACT background and aim The International Cancer of the Pancreas Screening Consortium met in 2018 to update its consensus recommendations for the management of individuals with increased risk of pancreatic cancer based on family history or germline mutation status (high- risk individuals). Methods A modified Delphi approach was employed to reach consensus among a multidisciplinary group of experts who voted on consensus statements. Consensus was considered reached if =75

2019 British Society of Gastroenterology

2. Assessment and Management of Patients at Risk for Suicide

Assessment and Management of Patients at Risk for Suicide VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE ASSESSMENT AND MANAGEMENT OF PATIENTS AT RISK FOR SUICIDE Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard (...) of recommendations for specific testing and/or therapeutic interventions within these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 2.0 – 2019VA/DoD Clinical Practice Guideline for the Assessment and Management of Patients at Risk for Suicide May 2019 Page 2 of 142 Prepared by: The Assessment and Management of Suicide Risk Work Group

2019 VA/DoD Clinical Practice Guidelines

3. Blood-borne viruses: managing potential risk in emergency workers

Blood-borne viruses: managing potential risk in emergency workers Blood-borne viruses: managing potential risk in emergency workers - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Blood-borne viruses: managing (...) potential risk in emergency workers Information on preventing and controlling the exposure of emergency service personnel to common blood-borne viruses. Published 4 October 2019 From: Documents Ref: PHE publications gateway number: GW-747 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document contains

2019 Public Health England

4. Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory

Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory EXPERT CONSENSUS DECISION PATHWAY 2019 ACC Expert Consensus Decision PathwayonRiskAssessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee Writing Committee Steven M. Hollenberg, MD, FACC, Chair Lynne Warner Stevenson, MD, FACC, Vice Chair Tariq Ahmad, MD, MPH, FACC Vaibhav J. Amin, MD (...) ,WarnerStevensonL,AhmadT,AminVJ,Bozkurt B, Butler J, Davis LL, Drazner MH, Kirkpatrick JN, Peterson PN, Reed BN, Roy CL, Storrow AB. 2019 ACC expert consensus decision pathway on risk assessment,management,andclinicaltrajectoryofpatientshospitalizedwithheartfailure:areportoftheAmericanCollegeofCardiologySolutionSet Oversight Committee. J Am Coll Cardiol 2019;XX:XXX–XX. Copies: This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). For copies of this document

2019 American College of Cardiology

5. Management of Infants at Risk for Group B Streptococcal Disease

Management of Infants at Risk for Group B Streptococcal Disease Management of Infants at Risk for Group B Streptococcal Disease | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. Management (...) adopted by neonatal physicians as a means of managing risk of all bacterial causes of early-onset sepsis (EOS). With implementation of universal maternal antenatal screening and IAP, the national incidence of GBS EOD has declined from 1.8 cases per 1000 live births in 1990 to 0.23 cases per 1000 live births in 2015. Evolving epidemiology, newly published data, and changing practice standards inform periodic review of practice guidelines. In 2017, representatives from the CDC, AAP, ACOG, and other

2019 American Academy of Pediatrics

6. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. (PubMed)

Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. In May 2019, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved an update to the 2013 joint clinical practice guideline for assessing and managing patients who are at risk for suicide. This guideline provides health care providers with a framework by which to screen for, evaluate (...) , treat, and manage the individual needs and preferences of VA and DoD patients who may be at risk for suicide.In January 2018, the VA/DoD Evidence-Based Practice Work Group convened to develop a joint VA/DoD guideline including clinical stakeholders and conforming to the National Academy of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel drafted key questions, systematically searched and evaluated the literature through April 2018, created algorithms, and advanced

2019 Annals of Internal Medicine

7. Diagnosis and management of patients at risk of gastric adenocarcinoma

Diagnosis and management of patients at risk of gastric adenocarcinoma British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma | Gut We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma Article Text Guidelines British Society of Gastroenterology guidelines on the diagnosis

2019 British Society of Gastroenterology

8. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations.

Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations - Journal of Vascular and Interventional Radiology Email/Username: Password (...) : Remember me Available now: Use your SIR login to access JVIR. Search Terms Search within Search Share this page Access provided by Article in Press Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe x

Full Text available with Trip Pro

2019 Society of Interventional Radiology

9. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations

Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical (...) Considerations - Journal of Vascular and Interventional Radiology Email/Username: Password: Remember me Available now: Use your SIR login to access JVIR. Search Terms Search within Search Share this page Access provided by Article in Press Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Endorsed

Full Text available with Trip Pro

2019 Society of Interventional Radiology

10. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. (PubMed)

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population.A representative sample of 57 779 adults aged 20 years or older was recruited (...) . Asthma was determined on the basis of a self-reported history of diagnosis by a physician or by wheezing symptoms in the preceding 12 months. All participants were assessed with a standard asthma questionnaire and were classed as having or not having airflow limitation through pulmonary function tests before and after the use of a bronchodilator (400 μg of salbutamol). Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants for whom data on the variables

2019 Lancet

11. 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy | Heart Rhythm Society Utility Menu Main navigation Search Main Menu Breadcrumb to access the pocket guide. Ablation Atrial Arrhythmias Clinical Ep Device Therapy Heart Failure / CRT Pediatric Training Ventricular Arrhythmias Downloads Improving the Care

2019 Heart Rhythm Society

12. Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This research programme developed new ways of predicting cardiovascular disease risk for people with severe mental illnesses, but an evidence-based practitioner-led intervention in primary care did not reduce cholesterol more than treatment as usual. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , , , , & . David

2019 NIHR HTA programme

13. Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health

Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health CYANOBACTERIA AND DRINKING WATER: OCCURRENCE, RISKS, MANAGEMENT AND KNOWLEDGE GAPS FOR PUBLIC HEALTH MARCH 2019 Prepared by: Juliette O’Keeffe National Collaborating Centre for Environmental Health Photo credit: Ake via rawpixelNational Collaborating Centre for Environmental Health 1 INTRODUCTION With warming temperatures due to climate change and increased nutrient loads to freshwater systems (...) of importance for public health (PH) professionals and others involved in water management in responding to current and future risks from cyanobacteria in drinking water. This review will outline: Key factors affecting the proliferation of cyanoblooms • The prevalence of cyanoblooms across Canada • The health effects from exposure to cyanotoxins and risks to drinking water supplies • The effectiveness of drinking water treatment for decreasing risks of exposure • Existing approaches to management

2019 National Collaborating Centre for Environmental Health

14. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT)

Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) - Regan - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term RCOG Scientific Impact Paper Free Access Prenatal Management of Pregnancies (...) detected antibodies in Caucasians are those directed against human platelet antigen (HPA)‐1a (80%) and HPA‐5b (10–15%), which can allow prediction of at‐risk fetuses. Where results are not supportive but clinical suspicion of FNAIT is high, further testing and management should be discussed with the diagnostic laboratory. The prenatal management of FNAIT has undergone a major shift over the past few years. There has been an increase in the use of immunoglobulins following evidence of probable efficacy

2019 Royal College of Obstetricians and Gynaecologists

15. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health CONSENSUS RECOMMENDATIONS Managementofgenitourinarysyndromeofmenopauseinwomenwith orathighriskforbreastcancer:consensusrecommendationsfromThe North American Menopause Society and The International Society for the Study of Women’s Sexual Health Stephanie S (...) forthese women. The Expert Consensus Panel iscomprised of a diverse group of 16 multidisciplinary experts wellrespectedintheirfields.Thepanelistsindividuallyconductedanevidence-basedreviewoftheliteratureintheir respective areas of expertise. They then met to discuss the latest treatment options for genitourinary syndrome of menopause (GSM) in survivors of breast cancer and review management strategies for GSM in women with or at high risk for breast cancer, using a modified Delphi method

2019 The North American Menopause Society

16. Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial

Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial Antisocial behavior and adult criminality often have origins in childhood and are best addressed early in the child's life using evidence-based parenting programs. However, families with additional risk factors do not always make sufficient changes while attending such programs; these families may benefit from additional support.To evaluate the efficacy (...) of adding a 10-session, structured home parent support (HPS) intervention to enhance outcomes for high-risk families attending the Incredible Years Parent (IYP) program.A randomized clinical superiority trial of 126 parents of children aged 3 to 7 years with conduct problems compared the IYP program plus HPS with treatment as usual of the IYP program alone. Child behavior measures were collected before and after treatment and at the 6-month follow-up. Recruitment from 19 IYP groups began February 13

2019 EvidenceUpdates

17. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department The Ottawa chronic obstructive pulmonary disease (COPD) Risk Scale (OCRS), which consists of 10 criteria, was previously derived to identify patients in the emergency department with COPD who were at high risk for short-term serious outcomes. We sought to validate, prospectively and explicitly, the OCRS when applied by physicians in the emergency (...) department.We conducted this prospective cohort study involving patients in the emergency departments at 6 tertiary care hospitals and enrolled adults with acute exacerbation of COPD from May 2011 to December 2013. Physicians evaluated patients for the OCRS criteria, which were recorded on a data form along with the total risk score. We followed patients for 30 days and the primary outcome, short-term serious outcomes, was defined as any of death, admission to monitored unit, intubation, noninvasive

Full Text available with Trip Pro

2019 EvidenceUpdates

18. Risks of harm with cannabinoids, cannabis and cannabis-based medicine for pain management relevant to patients receiving pain treatment: Protocol for an overview of systematic reviews

Risks of harm with cannabinoids, cannabis and cannabis-based medicine for pain management relevant to patients receiving pain treatment: Protocol for an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility (...) will be reported through a descriptive summary. ">Planned approach If a meta-analysis is planned , please specify the following:"> Example: number of metastases: standardized mean difference; incidence of metastasis: risk ratio. ">Effect measure The random-effects model is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size

2019 PROSPERO

19. Risk factors, prevalence, and management of chronic respiratory diseases in Nepal: a systematic review

Risk factors, prevalence, and management of chronic respiratory diseases in Nepal: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) is planned , please specify the following:"> Example: number of metastases: standardized mean difference; incidence of metastasis: risk ratio. ">Effect measure The random-effects model is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size), and that the true effect is the same (fixed) across all studies. However

2019 PROSPERO

20. Positive risk management in adult mental health: a review of policy and guidance

Positive risk management in adult mental health: a review of policy and guidance Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email (...) the following:"> Example: number of metastases: standardized mean difference; incidence of metastasis: risk ratio. ">Effect measure The random-effects model is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size), and that the true effect is the same (fixed) across all studies. However, this assumption is unlikely to hold

2019 PROSPERO